According to a new report, published by KBV research, The Global Diabetic Footwear Market size is expected to reach $13 billion by 2030, rising at a market growth of 8.0% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,75,471.8 thousand Units experiencing a growth of 8.0% (2019-2022).
The Men segment is experiencing a CAGR of 8.6% during (2023 - 2030). The increasing prevalence of diabetes among men globally has led to a higher demand for specialized diabetic footwear. As the diabetic population grows, so does the need for footwear that addresses the unique foot health challenges associated with diabetes, including neuropathy and reduced circulation. With age, individuals are more susceptible to diabetes and related complications, making them a key demographic for diabetic footwear. Therefore, the segment is expected to expand rapidly in the upcoming years.
The Shoes segment is generating the highest revenue in the Global Diabetic Footwear Market by Type in 2022; thereby, achieving a market value of $6.4 Billion by 2030. There is an increasing awareness among individuals with diabetes about the importance of foot health. Healthcare professionals and diabetes educators emphasize the role of proper footwear in preventing complications such as ulcers, infections, and amputations. This heightened awareness has led to a greater willingness among patients to invest in diabetic shoes. These factors will boost the demand in the segment.
The Footwear Stores segment would exhibit a CAGR of 8.5% during (2023 - 2030). Footwear stores, especially those specializing in diabetic footwear, may expand their product offerings to cater to a diverse consumer base. This could include a wider range of styles, designs, and customization options to meet the varying preferences and requirements of individuals with diabetes. The availability of fashionable and comfortable diabetic footwear may attract more customers to these stores. These factors will boost the demand in the segment.
The North America region dominated the Global Diabetic Footwear Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $4.9 Billion by 2030. The Europe market is anticipated to grow a CAGR of 7.8% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 8.8% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/diabetic-footwear-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of New Balance Athletics, Inc., SKECHERS USA, Inc., Orthofeet, Inc. (Webster Equity Partners), DJO Global (Enovis Corporation), Drew Shoe Corporation, Wolverine World Wide, Inc., Podartis Srl, I-Runner (Healer Health LLC), Pilgrim Shoes and Aetrx Worldwide, Inc.
By End User (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Distribution Channel (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Billion/Million, 2019-2030)
Companies Profiled
Unique Offerings 
